References
- Barratt G., Puisieux F., Yu W. P., Foucher C, Fessi H., Devissaguet J. P. Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. Int. J. Immunopharm. 1994; 16: 457–461
- Brasseur E. L., Couvreur P., Kanta B., Deckers-Passau L., Roland M., Deckers C., Speiser P. Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor. Eur. J. Cancer 1980; 16: 1441–1445
- Chang T MS. Biodegradable microcapsules containing enzymes, hormones, vaccines and other biologicals. Journal of Bioengineering 1976; 1: 25
- Couvreur P., Kante B., Roland M., Speiser P. Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J. Pharm. Sci. 1982; 71: 790–792
- Crump B., Wise R., Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983; 26(5)784
- Hoffken G., Lode H., Prinzing C, Borner K., Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrobial Agents and Chemotherapy 1985; 27(3)375
- Losa C, Calvo P., Castro E., Vila-Jato L., Alonso M. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J. Pharm. Pharmacol. 1991; 43: 548–552
- Martinez B., Lairion F., Pena M. B., Di Rocco P., Nacucchio M. C. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres. J. Microencapsulation 1997; 14(2)155–161
- Morin C, Fessi H., Devissaguet J. P., Puisieux F., Barratt G. Factors influencing macrophage activation by muramyl peptides: inhibition oh NO synthase activity by high levels of NO. Biochimica et Biophysica Acta. 1994; 427–432; 1224
- Owusu-Ababio. Efficacy of sustained release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model. J. Med. Microbiol. 1995; 43: 368–376
- Wong J. P., Cherwonogrodzky J. W., Di Ninno V.L., Delacruz R., Saravolac E. G. Liposome-encapsulated ciprofloxacin for the prevention and treatment of infections diseases caused by intracellar pathogens. Liposomes in Biomedical Applications, P.N. Shek. Harwood Acad. Press, AmsterdamHolland 1995; 105–134
- Yu W. P., Foucher C, Barratt G., Fessi H., Devissaguet J. P., Puisieux F. Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. Eme Congres International de Technologie Pharmaceutique. APGI, Paris 1992; III: 83–92
- Yu WP, Wong J., Chang TMS. Preparation and characterization of polylactic acid microcapsules containing ciprofloxacin for controlled release. J. Microencapsulation 1998; 15: 515–523
- Zimmer A., Mutshler E., Lambrecht G., Mayer D., Kreuter J. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle delivery system. Pharm. Res 1994; 11(10)1435–1442